Share this
Map

DHPLC WAVE system 4500HT

Transgenomic WAVE® System; DHPLC (denaturing high-performance liquid chromatography); detection of known and unknown mutations and single nucleotide polymorphisms (SNPs).

DHPLC WAVE system 4500HT

Contacts and Location

Contact 1 Zanda Daneberga
Contact 2 Linda Gabrusenoka
Enquire about this equipment
Organisational Unit Rīga Stradiņš University
    Institute of Oncology - Latvia, Rīga

Description

Transgenomic WAVE® System; DHPLC (denaturing high-performance liquid chromatography); detection of known and unknown mutations and single nucleotide polymorphisms (SNPs).

Specification

DNASep® HT Cartridge - Patented column filled with non-porous matrix consisting of polystyrene-divinylbenzene (PS-DVB) copolymer microspheres. Injection capacity: 0.5 ng to 4 µg. Low Pressure Gradient Solvent Delivery System. Autosampler capability: 2 x 96 samples and 1 x 384 samples. Autosampler temperature: Factory present 14 °C ± 1 °C, adjustable: 4 °C to ambient. Sample volume: 200 µL max. on 96-well plate, higher on optional 48 well-plate. Injection volume: 1 - 450 µL; up to 2 mL with optional syringe.

Services

Transgenomic WAVE® Systems utilize DHPLC (denaturing high-performance liquid chromatography) in conjunction with the Transgenomic patented separation DNASep® Cartridges for mutation detection. WAVE Systems offer discovery and detection of genetic variation at close to 100% sensitivity— making it one of the most sensitive and accurate technologies for detection of known and unknown mutations and single nucleotide polymorphisms (SNPs).

Status

Engaged in service

Funding Source

National Research Centers (VNPC) -
Back to all

Manufacturer

Transgenomic Inc. (manufacturer's website)

Model

WAVE system 4500HT

Availability

Information on availability on request

Access Level

Full Access

Calibrated

Yes, this equipment is calibrated.

Contract price
Enquire
or

Permanent Link

Similar equipment
0 items in cart
Total: 0
You have no items in a cart
Go to checkout
Go Enquire